Cabaletta Bio (CABA) Other financing activities (2020 - 2025)

Cabaletta Bio's Other financing activities history runs 6 years deep, the most recent figure standing at -$183000.0 for Q3 2025.

• On a quarterly basis, Other financing activities fell 114.07% year-over-year to -$183000.0 in Q3 2025; TTM through Dec 2025 was $14000.0, a 99.02% decrease from a year earlier, with the FY2025 full-year figure at $14000.0, down 99.02% from the prior year.
• Other financing activities declined to -$183000.0 in Q3 2025 per CABA's latest filing, from $197000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $2.3 million in Q4 2023 and bottomed at -$980000.0 in Q2 2024.
• The 5-year median for Other financing activities is $197000.0 (2025), against an average of $347909.1.
• Across the five-year window, Other financing activities tumbled 11300.0% in 2021 and soared 798.04% in 2023, its largest moves.
• Year by year, Other financing activities stood at -$448000.0 in 2021, then jumped by 111.38% to $51000.0 in 2022, then surged by 4388.24% to $2.3 million in 2023, then slumped by 43.16% to $1.3 million in 2024, then slumped by 114.07% to -$183000.0 in 2025.
• Per Business Quant, the three latest CABA Other financing activities figures stand at -$183000.0 (Q3 2025), $197000.0 (Q2 2025), and $1.3 million (Q3 2024).